Tango Therapeutics (NASDAQ:TNGX) reported its Q3 earnings results on Wednesday, November 8, 2023 at 07:00 AM.
Here’s what investors need to know about the announcement.
Earnings
Tango Therapeutics beat estimated earnings by 32.35%, reporting an EPS of $-0.23 versus an estimate of $-0.34.
Revenue was up $3.81 million from the same period last year.
Past Earnings Performance
Last quarter the company beat on EPS by $0.11 which was followed by a 11.34% increase in the share price the next day.
Here’s a look at Tango Therapeutics’s past performance:
| Quarter | Q2 2023 | Q1 2023 | Q4 2022 | Q3 2022 |
|---|---|---|---|---|
| EPS Estimate | -0.34 | -0.35 | -0.35 | -0.32 |
| EPS Actual | -0.23 | -0.32 | -0.33 | -0.33 |
| Revenue Estimate | 6.95M | 6.71M | 6.44M | 5.53M |
| Revenue Actual | 14.60M | 5.77M | 6.41M | 6.92M |
** Listen to the earnings announcement yourself by clicking here. **
To track all earnings releases for Tango Therapeutics visit their earnings calendar here.
This article was generated by Benzinga’s automated content engine and reviewed by an editor.
